Julia Hettinger

2.0k total citations
13 papers, 423 citations indexed

About

Julia Hettinger is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Julia Hettinger has authored 13 papers receiving a total of 423 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Hematology and 3 papers in Genetics. Recurrent topics in Julia Hettinger's work include Blood Coagulation and Thrombosis Mechanisms (3 papers), Cancer-related gene regulation (3 papers) and Hemophilia Treatment and Research (3 papers). Julia Hettinger is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (3 papers), Cancer-related gene regulation (3 papers) and Hemophilia Treatment and Research (3 papers). Julia Hettinger collaborates with scholars based in United States. Julia Hettinger's co-authors include Brian R. Bettencourt, Tim Racie, Paul J. Schmidt, Mark D. Fleming, Stuart Milstein, Anoop K. Sendamarai, David Bumcrot, Iva Toudjarska, Kevin Fitzgerald and Xingsheng Li and has published in prestigious journals such as Blood, Journal of the American Society of Nephrology and Journal of Hepatology.

In The Last Decade

Julia Hettinger

13 papers receiving 417 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Julia Hettinger United States	6	196	183	173	83	82	13	423
AK Burnett United Kingdom	9	346 1.8×	204 1.1×	64 0.4×	25 0.3×	170 2.1×	16	469
Rafael Marino Canada	7	76 0.4×	142 0.8×	54 0.3×	47 0.6×	51 0.6×	11	369
Aneta Bałabas Poland	12	80 0.4×	32 0.2×	152 0.9×	66 0.8×	40 0.5×	36	403
Nargess Arandi Iran	13	135 0.7×	56 0.3×	58 0.3×	45 0.5×	19 0.2×	32	400
C Hesketh United Kingdom	7	236 1.2×	309 1.7×	121 0.7×	25 0.3×	9 0.1×	7	432
Masakazu Sawanobori Japan	9	166 0.8×	38 0.2×	97 0.6×	17 0.2×	49 0.6×	17	357
A C Fay United Kingdom	10	135 0.7×	326 1.8×	61 0.4×	14 0.2×	106 1.3×	23	558
Carole Barin France	10	142 0.7×	50 0.3×	101 0.6×	23 0.3×	29 0.4×	16	302
Thomas Hofstra United States	8	379 1.9×	303 1.7×	38 0.2×	17 0.2×	66 0.8×	14	462
Ji‐Young Lim South Korea	13	161 0.8×	83 0.5×	138 0.8×	29 0.3×	9 0.1×	32	415

Countries citing papers authored by Julia Hettinger

Since Specialization

Citations

This map shows the geographic impact of Julia Hettinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia Hettinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia Hettinger more than expected).

Fields of papers citing papers by Julia Hettinger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia Hettinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia Hettinger. The network helps show where Julia Hettinger may publish in the future.

Co-authorship network of co-authors of Julia Hettinger

This figure shows the co-authorship network connecting the top 25 collaborators of Julia Hettinger. A scholar is included among the top collaborators of Julia Hettinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julia Hettinger. Julia Hettinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Sutherland, Jessica E., Julia Hettinger, Amy Chan, et al.. (2019). Nonclinical Safety Profile of Revusiran, a 1st-Generation GalNAc-siRNA Conjugate for Treatment of Hereditary Transthyretin-Mediated Amyloidosis. Nucleic Acid Therapeutics. 30(1). 33–49. 19 indexed citations

Schmidt, Paul J., Kaifeng Liu, Gary Visner, et al.. (2018). RNAi‐mediated reduction of hepatic Tmprss6 diminishes anemia and secondary iron overload in a splenectomized mouse model of β‐thalassemia intermedia. American Journal of Hematology. 93(6). 745–750. 18 indexed citations

Berg, Thomas, Albrecht Stoehr, G Teuber, et al.. (2018). First real-world data on safety and effectiveness of glecaprevir/pibrentasvir for the treatment of patients with chronic hepatitis C virus infection: Data from the German Hepatitis C-Registry. Journal of Hepatology. 68. S37–S37. 4 indexed citations

Hinrichsen, Holger, H. Wedemeyer, Stefan Christensen, et al.. (2016). Real-World Safety and Effectiveness of Ombitasvir/ Paritaprevir/R with Dasabuvir and/or Ribavirin in the German Hepatitis C Registry. Journal of Hepatology. 64(2). S159–S159. 12 indexed citations

Liebow, Abigail, Xingsheng Li, Timothy Racie, et al.. (2016). An Investigational RNAi Therapeutic Targeting Glycolate Oxidase Reduces Oxalate Production in Models of Primary Hyperoxaluria. Journal of the American Society of Nephrology. 28(2). 494–503. 159 indexed citations

Hettinger, Julia, et al.. (2016). Mitochondrial DNA sequence variation inHippopotamus amphibiusfrom Kruger National Park, Republic of South Africa. African Zoology. 51(2). 77–82. 2 indexed citations

Barros, Scott, Julia Hettinger, Yongfeng Jiang, et al.. (2013). Expanded Therapeutic Index Of Antithrombin Silencing and Correction Of Aptt In a Hemophilia A Mouse Model. Blood. 122(21). 3585–3585. 1 indexed citations

Butler, James, Tim Racie, Julia Hettinger, et al.. (2013). Aln-TMP: A Subcutaneously Administered RNAi Therapeutic Targeting Tmprss6 For The Treatment Of β-Thalassemia. Blood. 122(21). 2260–2260. 4 indexed citations

Akinc, Akin, Alfica Sehgal, Scott Barros, et al.. (2012). An RNAi Therapeutic Targeting Antithrombin Increases Thrombin Generation in Nonhuman Primates. Blood. 120(21). 3370–3370. 5 indexed citations

10.

Schmidt, Paul J., Iva Toudjarska, Anoop K. Sendamarai, et al.. (2012). An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe−/− mice and ameliorates anemia and iron overload in murine β-thalassemia intermedia. Blood. 121(7). 1200–1208. 171 indexed citations

11.

Akinc, Akin, Alfica Sehgal, Don Foster, et al.. (2011). Targeting the Hepcidin Pathway with RNAi Therapeutics for the Treatment of Anemia. Blood. 118(21). 688–688. 24 indexed citations

12.

Querbes, William, Roman L. Bogorad, Javid J. Moslehi, et al.. (2011). Liver Specific Delivery of siRNA Targeting EGLN Prolyl Hydroxylases Activates Hepatic Erythropoietin Production and Stimulates Erythropoiesis,. Blood. 118(21). 3161–3161. 1 indexed citations

13.

Toudjarska, Ivanka, Tim Racie, Julia Hettinger, et al.. (2011). RNAi-Mediated Inhibition of Activated Protein C- A New Approach for Hemophilia Treatment. Blood. 118(21). 1204–1204. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact